Free Trial

Organigram Q3 2024 Earnings Report

Organigram logo
C$1.82 -0.01 (-0.55%)
As of 02/21/2025 04:00 PM Eastern

Organigram EPS Results

Actual EPS
C$0.03
Consensus EPS
-C$0.07
Beat/Miss
Beat by +C$0.10
One Year Ago EPS
N/A

Organigram Revenue Results

Actual Revenue
$41.06 million
Expected Revenue
$39.20 million
Beat/Miss
Beat by +$1.86 million
YoY Revenue Growth
N/A

Organigram Announcement Details

Quarter
Q3 2024
Time
N/A

Conference Call Resources

Organigram Earnings Headlines

Alliance Global Partners Estimates Organigram Q3 Earnings
Q3 EPS Estimates for Organigram Reduced by Atb Cap Markets
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blueprint. And I have something surprising to tell you about it … It doesn't include Nvidia.
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (TSE:OGI) Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

View Organigram Profile

More Earnings Resources from MarketBeat